Please enable JavaScript to continue using this application.

Compare $BIO vs $SHC | Chartloom

Compare

$BIO vs $SHC

Bio Rad Laboratories Inc · Sotera Health Co

BIO

Bio Rad Laboratories Inc

SHC

Sotera Health Co

Compare $BIO vs $SHC

Comparing Bio Rad Laboratories Inc and Sotera Health Co

BIOBio Rad Laboratories Inc

SHCSotera Health Co

BIOBio Rad Laboratories Inc

Market cap

$9.80B

P/E (TTM)

44.15x

Forward P/E (NTM)

33.67x

Forward P/S (NTM)

3.70x

Rev growth (TTM)

1.4%

YTD performance

19.9%

52W performance

20.9%

FCF yield

3.6%

SHCSotera Health Co

Market cap

$5.15B

P/E (TTM)

31.83x

Forward P/E (NTM)

17.43x

Forward P/S (NTM)

3.98x

Rev growth (TTM)

8.1%

YTD performance

2.1%

52W performance

12.9%

FCF yield

2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIO

SHC

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

SHC

Sotera Health Co

Market Cap

BIO$9.80B

SHC$5.15B

Enterprise Value

BIO$10.49B

SHC$7.03B

Price

BIO$366.16

SHC$18.06

P/E Ratio

BIO44.15x

SHC31.83x

P/S Ratio

BIO3.78x

SHC4.23x

EV/Sales

BIO4.05x

SHC5.78x

EV/EBITDA

BIO15.48x

SHC13.41x

P/B Ratio

BIO1.38x

SHC7.81x

P/FCF Ratio

BIO27.75x

SHC45.70x

EV/FCF

BIO29.69x

SHC62.36x

PEG Ratio

BION/A

SHC3.19x

Forward P/E (NTM)

BIO33.67x

SHC17.43x

Forward P/S (NTM)

BIO3.70x

SHC3.98x

Revenue (TTM)

BIO$2.59B

SHC$1.22B

Revenue Growth (YoY)

BIO1.4%

SHC8.1%

Forward Rev Growth

BIO2.9%

SHC6.0%

Gross Margin (TTM)

BIO51.9%

SHC55.0%

Operating Margin (TTM)

BIO1.8%

SHC32.6%

EBITDA Margin (TTM)

BIO9.1%

SHC43.1%

Net Margin (TTM)

BIO8.6%

SHC13.4%

FCF Margin (TTM)

BIO13.6%

SHC9.3%

Net Income (TTM)

BIO$222M

SHC$163M

FCF (TTM)

BIO$353M

SHC$113M

EPS (TTM)

BIO$8.29

SHC$0.57

ROE (TTM)

BIO3.1%

SHC26.8%

ROA (TTM)

BIO2.2%

SHC5.0%

ROIC (TTM)

BIO2.7%

SHC5.7%

Cash

BIO$517M

SHC$357M

Debt

BIO$1.20B

SHC$2.23B

Net Cash/Debt

BIO$-687M

SHC$-1.88B

Current Ratio (TTM)

BIO3.14x

SHC2.80x

Quick Ratio (TTM)

BIO2.18x

SHC2.45x

Debt/Equity (TTM)

BIO0.17x

SHC3.36x

Debt/Assets (TTM)

BIO0.0%

SHC0.0%

Interest Coverage (TTM)

BION/A

SHCN/A

Net Debt/EBITDA (TTM)

BIO0.00x

SHC0.00x

Beta

BIO1.07

SHC1.93

52W Performance

BIO20.9%

SHC12.9%

YTD Performance

BIO19.9%

SHC2.1%

% from 52W High

BIO-7.6%

SHC-9.0%

% from 52W Low

BIO54.7%

SHC38.0%

Asset Turnover (TTM)

BIO0.26x

SHC0.37x

FCF Yield (TTM)

BIO3.6%

SHC2.2%

Earnings Yield (TTM)

BIO2.3%

SHC3.2%

Dividend Yield (TTM)

BION/A

SHCN/A

Rule of 40

BIO15.0

SHC17.4

EV/GP/RG

BIO1.18

SHC1.64

Ticker research

View BIO research View SHC research

Metric	BIO Bio Rad Laboratories Inc	SHC Sotera Health Co
Market & Valuation
Market Cap	$9.80B	$5.15B
Enterprise Value	$10.49B	$7.03B
Price	$366.16	$18.06
P/E Ratio	44.15x	31.83x
P/S Ratio	3.78x	4.23x
EV/Sales	4.05x	5.78x
EV/EBITDA	15.48x	13.41x
P/B Ratio	1.38x	7.81x
P/FCF Ratio	27.75x	45.70x
EV/FCF	29.69x	62.36x
PEG Ratio	N/A	3.19x
Forward P/E (NTM)	33.67x	17.43x
Forward P/S (NTM)	3.70x	3.98x
Revenue & Growth
Revenue (TTM)	$2.59B	$1.22B
Revenue Growth (YoY)	1.4%	8.1%
Forward Rev Growth	2.9%	6.0%
Profitability
Gross Margin (TTM)	51.9%	55.0%
Operating Margin (TTM)	1.8%	32.6%
EBITDA Margin (TTM)	9.1%	43.1%
Net Margin (TTM)	8.6%	13.4%
FCF Margin (TTM)	13.6%	9.3%
Net Income (TTM)	$222M	$163M
FCF (TTM)	$353M	$113M
EPS (TTM)	$8.29	$0.57
ROE (TTM)	3.1%	26.8%
ROA (TTM)	2.2%	5.0%
ROIC (TTM)	2.7%	5.7%
Financial Health
Cash	$517M	$357M
Debt	$1.20B	$2.23B
Net Cash/Debt	$-687M	$-1.88B
Current Ratio (TTM)	3.14x	2.80x
Quick Ratio (TTM)	2.18x	2.45x
Debt/Equity (TTM)	0.17x	3.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.93
52W Performance	20.9%	12.9%
YTD Performance	19.9%	2.1%
% from 52W High	-7.6%	-9.0%
% from 52W Low	54.7%	38.0%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.37x
FCF Yield (TTM)	3.6%	2.2%
Earnings Yield (TTM)	2.3%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	15.0	17.4
EV/GP/RG	1.18	1.64
Ticker research	View BIO research	View SHC research

Valuation

P/E Ratio

SHC

31.83x

BIO

44.15x

P/S Ratio

BIO

3.78x

SHC

4.23x

EV/FCF

BIO

29.69x

SHC

62.36x

Growth & revenue

Revenue Growth TTM

SHC

8.1%

BIO

1.4%

Forward Revenue Growth

SHC

6.0%

BIO

2.9%

Profitability & performance

Gross Margin

SHC

55.0%

BIO

51.9%

ROE

SHC

26.8%

BIO

3.1%

FCF Yield %

BIO

3.6%

SHC

2.2%

52-Week Performance

BIO

20.9%

SHC

12.9%

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

SHC

Sotera Health Co

Market Cap

BIO$9.80B

SHC$5.15B

Enterprise Value

BIO$10.49B

SHC$7.03B

Price

BIO$366.16

SHC$18.06

P/E Ratio

BIO44.15x

SHC31.83x

P/S Ratio

BIO3.78x

SHC4.23x

EV/Sales

BIO4.05x

SHC5.78x

EV/EBITDA

BIO15.48x

SHC13.41x

P/B Ratio

BIO1.38x

SHC7.81x

P/FCF Ratio

BIO27.75x

SHC45.70x

EV/FCF

BIO29.69x

SHC62.36x

PEG Ratio

BION/A

SHC3.19x

Forward P/E (NTM)

BIO33.67x

SHC17.43x

Forward P/S (NTM)

BIO3.70x

SHC3.98x

Revenue (TTM)

BIO$2.59B

SHC$1.22B

Revenue Growth (YoY)

BIO1.4%

SHC8.1%

Forward Rev Growth

BIO2.9%

SHC6.0%

Gross Margin (TTM)

BIO51.9%

SHC55.0%

Operating Margin (TTM)

BIO1.8%

SHC32.6%

EBITDA Margin (TTM)

BIO9.1%

SHC43.1%

Net Margin (TTM)

BIO8.6%

SHC13.4%

FCF Margin (TTM)

BIO13.6%

SHC9.3%

Net Income (TTM)

BIO$222M

SHC$163M

FCF (TTM)

BIO$353M

SHC$113M

EPS (TTM)

BIO$8.29

SHC$0.57

ROE (TTM)

BIO3.1%

SHC26.8%

ROA (TTM)

BIO2.2%

SHC5.0%

ROIC (TTM)

BIO2.7%

SHC5.7%

Cash

BIO$517M

SHC$357M

Debt

BIO$1.20B

SHC$2.23B

Net Cash/Debt

BIO$-687M

SHC$-1.88B

Current Ratio (TTM)

BIO3.14x

SHC2.80x

Quick Ratio (TTM)

BIO2.18x

SHC2.45x

Debt/Equity (TTM)

BIO0.17x

SHC3.36x

Debt/Assets (TTM)

BIO0.0%

SHC0.0%

Interest Coverage (TTM)

BION/A

SHCN/A

Net Debt/EBITDA (TTM)

BIO0.00x

SHC0.00x

Beta

BIO1.07

SHC1.93

52W Performance

BIO20.9%

SHC12.9%

YTD Performance

BIO19.9%

SHC2.1%

% from 52W High

BIO-7.6%

SHC-9.0%

% from 52W Low

BIO54.7%

SHC38.0%

Asset Turnover (TTM)

BIO0.26x

SHC0.37x

FCF Yield (TTM)

BIO3.6%

SHC2.2%

Earnings Yield (TTM)

BIO2.3%

SHC3.2%

Dividend Yield (TTM)

BION/A

SHCN/A

Rule of 40

BIO15.0

SHC17.4

EV/GP/RG

BIO1.18

SHC1.64

Ticker research

View BIO research View SHC research

Metric	BIO Bio Rad Laboratories Inc	SHC Sotera Health Co
Market & Valuation
Market Cap	$9.80B	$5.15B
Enterprise Value	$10.49B	$7.03B
Price	$366.16	$18.06
P/E Ratio	44.15x	31.83x
P/S Ratio	3.78x	4.23x
EV/Sales	4.05x	5.78x
EV/EBITDA	15.48x	13.41x
P/B Ratio	1.38x	7.81x
P/FCF Ratio	27.75x	45.70x
EV/FCF	29.69x	62.36x
PEG Ratio	N/A	3.19x
Forward P/E (NTM)	33.67x	17.43x
Forward P/S (NTM)	3.70x	3.98x
Revenue & Growth
Revenue (TTM)	$2.59B	$1.22B
Revenue Growth (YoY)	1.4%	8.1%
Forward Rev Growth	2.9%	6.0%
Profitability
Gross Margin (TTM)	51.9%	55.0%
Operating Margin (TTM)	1.8%	32.6%
EBITDA Margin (TTM)	9.1%	43.1%
Net Margin (TTM)	8.6%	13.4%
FCF Margin (TTM)	13.6%	9.3%
Net Income (TTM)	$222M	$163M
FCF (TTM)	$353M	$113M
EPS (TTM)	$8.29	$0.57
ROE (TTM)	3.1%	26.8%
ROA (TTM)	2.2%	5.0%
ROIC (TTM)	2.7%	5.7%
Financial Health
Cash	$517M	$357M
Debt	$1.20B	$2.23B
Net Cash/Debt	$-687M	$-1.88B
Current Ratio (TTM)	3.14x	2.80x
Quick Ratio (TTM)	2.18x	2.45x
Debt/Equity (TTM)	0.17x	3.36x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.93
52W Performance	20.9%	12.9%
YTD Performance	19.9%	2.1%
% from 52W High	-7.6%	-9.0%
% from 52W Low	54.7%	38.0%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.37x
FCF Yield (TTM)	3.6%	2.2%
Earnings Yield (TTM)	2.3%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	15.0	17.4
EV/GP/RG	1.18	1.64
Ticker research	View BIO research	View SHC research